...
首页> 外文期刊>Journal of Clinical Microbiology >Molecular Fine-Specificity Analysis of Antibody Responses to Human Cytomegalovirus and Design of Novel Synthetic-Peptide-Based Serodiagnostic Assays
【24h】

Molecular Fine-Specificity Analysis of Antibody Responses to Human Cytomegalovirus and Design of Novel Synthetic-Peptide-Based Serodiagnostic Assays

机译:对人巨细胞病毒抗体应答的分子精细特异性分析和基于新型合成肽的血清诊断方法的设计

获取原文
   

获取外文期刊封面封底 >>

       

摘要

To identify single immunodominant marker proteins which can replace complex virion antigen in serodiagnostic assays, we investigated in detail the molecular fine specificity of antibody responses in different individuals with latent or active human cytomegalovirus (HCMV) infection. An overview of the HCMV proteins recognized by human antibodies was obtained by immunoblotting. For selected immunodominant proteins the epitope fine specificity of the antibody response was determined by a peptide-scanning enzyme-linked immunosorbent assay (ELISA). Epitope clusters were synthesized as combination peptides and were used for further serologic analysis of immunoglobulin M (IgM) and IgG reactivities with panels of sera from different groups of patients in comparison to those with cytomegalovirus (CMV) virion antigen. Several serum samples had significantly higher reactivities with peptides than with the CMV virion antigen. However, individual serum samples occasionally recognized diverse peptide epitopes, stressing the importance of using combinations of peptides in serologic assays. From these studies we were able to define a specific combination of peptides derived from pp52 (UL44) and pp150 (UL32) for the specific and highly sensitive early detection of HCMV IgM, whereas a combination of peptides from pp150 (UL32), gB (UL55), and pp28 (UL99) was selected to give optimal and specific reactivity with HCMV IgG. On the basis of the results obtained with these peptide combinations, new, highly specific serodiagnostic assays were constructed. These assays had sensitivities of 98.9 and 96.4% for IgG and IgM, respectively, in comparison with the results obtained with the “gold standard,” the virion antigen-based ELISA. From the results of this study we conclude that specific combinations of highly defined synthetic peptides can replace complex HCMV virion extracts used in current serodiagnostics and may add to further standardization of HCMV serology.
机译:为了鉴定可以在血清诊断分析中替代复杂病毒粒子抗原的单一免疫优势标记蛋白,我们详细研究了具有潜伏性或活动性人类巨细胞病毒(HCMV)感染的不同个体中抗体反应的分子精细特异性。通过免疫印迹获得了人抗体识别的HCMV蛋白的概述。对于选定的免疫优势蛋白,通过肽扫描酶联免疫吸附测定(ELISA)确定抗体反应的表位精细特异性。表位簇被合成为组合肽,并与来自巨细胞病毒(CMV)病毒粒子抗原的患者相比,用于不同患者血清的免疫球蛋白M(IgM)和IgG反应性的进一步血清学分析。与CMV病毒粒子抗原相比,几种血清样品对肽的反应性明显更高。但是,个别血清样本偶尔会识别出多种肽表位,从而强调了在血清学检测中使用肽组合的重要性。从这些研究中,我们能够定义源自pp52(UL44)和pp150(UL32)的肽的特定组合,用于HCMV IgM的特异性和高度灵敏的早期检测,而来自pp150(UL32),gB(UL55)的肽的组合),然后选择pp28(UL99)以提供与HCMV IgG的最佳和特异性反应性。基于这些肽组合获得的结果,构建了新的高度特异性的血清诊断方法。与使用“金标准”(基于病毒体抗原的ELISA)获得的结果相比,这些测定对IgG和IgM的敏感性分别为98.9%和96.4%。根据这项研究的结果,我们得出结论,高定义的合成肽的特定组合可以替代当前血清学诊断中使用的复杂HCMV病毒体提取物,并可能进一步增加HCMV血清学的标准化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号